Anaptysbio (ANAB) Net Income (2016 - 2026)
Anaptysbio (ANAB) reported Net Income of -$52.88 million for Q1 2026, compared with -$39.33 million a year earlier.
Powered by 
Analysis
Anaptysbio (ANAB) Net Income (2016 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Anaptysbio's Net Income came in at -$26.79 million; for FY2025, it was -$13.23 million.
- By year, Net Income came in at -$145.23 million in FY2024, -$163.62 million in FY2023, -$128.72 million in FY2022 and -$57.8 million in FY2021.
- The Q1 2026 figure ranks as the lowest quarterly Net Income in data going back to Q1 2016.
- Per Business Quant data, the three quarters before Q1 2026 came in at $49.61 million (Q4 2025), $15.11 million (Q3 2025) and -$38.63 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Anaptysbio | 1.46 Bn | 346.34 Mn | - | -52.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -52.88 Mn |
| Dec 31, 2025 | 49.61 Mn |
| Sep 30, 2025 | 15.11 Mn |
| Jun 30, 2025 | -38.63 Mn |
| Mar 31, 2025 | -39.33 Mn |
| Dec 31, 2024 | -21.78 Mn |
| Sep 30, 2024 | -32.85 Mn |
| Jun 30, 2024 | -46.66 Mn |
| Mar 31, 2024 | -43.94 Mn |
| Dec 31, 2023 | -42.21 Mn |
| Sep 30, 2023 | -37.31 Mn |
| Jun 30, 2023 | -39.85 Mn |
| Mar 31, 2023 | -39.92 Mn |
| Dec 31, 2022 | -22.13 Mn |
| Sep 30, 2022 | -27.37 Mn |
| Jun 30, 2022 | -26.69 Mn |
| Mar 31, 2022 | -31.41 Mn |
| Dec 31, 2021 | -31.09 Mn |
| Sep 30, 2021 | -6.70 Mn |
| Jun 30, 2021 | -429,000.00 |
API Access
Anaptysbio Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();